AstraZeneca finds small clot risk after 1st COVID shot, less after 2nd
Pushkala Aripaka, Reuters
Posted at Jul 28 06:55 PM
AstraZeneca's COVID-19 vaccine carries a small extra risk of rare blood clots with low platelets after the first dose and no extra risk after the second, a study led and funded by the drugmaker showed on Wednesday, after worries over side-effects.
Read more »